뉴스

• Biotech Stocks Rally Despite Peptron, HLB Shocks[K-Bio Pulse] Peptron and HLB Group companies plunged to their daily lower limits on July 10 amid separate setbacks. Despite the sharp selloffs, buying momentum spread across www.edaily.co.kr · 2026.07.11
• Remedi Surges, HLB Hits Limit Down as FDA Blow Weighs[K-Bio Pulse] The Korean biotech sector saw sharply diverging performances on July 13, with newly listed Remedi. emerging as the day's standout performer, while HLB extended www.edaily.co.kr · 2026.07.14
• HLB Hits Limit-Up on FDA Optimism; Curiosis, Peptron Rebound Sharply [K-Bio Pulse] On July 15, South Korean pharmaceutical and biotech stocks rallied, led by a broad surge in HLB affiliates, while Curiosis and Peptron posted double-digit gains www.edaily.co.kr · 2026.07.16
• HLB Jumps on FDA Review Hopes...Seers Rznomics Rally[K-Bio Pulse] On June 16, South Korea’s pharmaceutical and biotechnology stocks traded largely on company-specific catalysts, including regulatory expectations, busines www.edaily.co.kr · 2026.06.17